[1] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. [2] PARIZADEH S M,JAFARZADEH-ESFEHANI R,GHANDEHARI M,et al.Circulating and tissue microRNAs as biomarkers for ovarian cancer prognosis[J].Curr Drug Targets,2019,20(14):1447-1460. [3] DEB B,UDDIN A,CHAKRABORTY S.miRNAs and ovarian cancer:an overview[J].J Cell Physiol,2018,233(5):3846-3854. [4] FU X D,LI Y M,ALVERO A,et al.MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival[J].Oncotarget,2016,7(49):80633-80654. [5] CHEN L,YANG X,ABASI X,et al.The diagnostic,prediction of postoperative recurrence and prognostic value of HE4 in epithelial ovarian cancer[J].J BUON,2018,23(2):428-432. [6] CHEN L F,WANG X Y,SHU J,et al.Diagnostic value of serum D-dimer,CA125,and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis[J].Int J Gynaecol Obstet,2019,147(2):212-218. [7] 索红燕, 孔为民.《国际妇产科联盟(FIGO)2018癌症报告:卵巢上皮性癌、输卵管癌和腹膜癌指南》解读[J].中国临床医生杂志, 2019, 47(8):905-907. [8] OLIVEIRA D N P,CARLSEN A L,HEEGAARD N H H,et al.Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass[J].PLoS One,2019,14(11):e0225249. [9] ZÁVESKÝ L,JANDÁKOVÁ E,WEINBERGER V,et al.Ovarian cancer:differentially expressed microRNAs in tumor tissue and cell-free ascitic fluid as potential novel biomarkers[J].Cancer Invest,2019,37(9):440-452. [10] LIU X Q,LI G H.MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor[J].Int J Clin Exp Pathol,2015,8(9):10605-10614. [11] ZHANG X,LIU J,ZANG D,et al.Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression[J].Oncotarget,2015,6(17):15180-15193. [12] WU G Y,LIU A B,ZHU J R,et al.MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway[J].Oncotarget,2015,6(30):28882-28894. [13] 杨堃,魏佳希.HE4联合CA125检测在卵巢癌患者中的应用及诊断价值研究[J].中国性科学,2019,28(6):38-41. [14] YING X,WU Q F,WU X L,et al.Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages[J].Oncotarget,2016,7(28):43076-43087. [15] 唐梅,林丽慧,林元,等.血清人附睾蛋白4与CA125在上皮性卵巢癌中的表达及其与预后的关系[J].解放军医学院学报,2018,39(1):24-27. [16] PAN C,STEVIC I,MÜLLER V,et al.Exosomal microRNAs as tumor markers in epithelial ovarian cancer[J].Mol Oncol,2018,12(11):1935-1948. [17] 王丹,代晶,潘长清,等.血清CA125、HE4以及ROMA指数在卵巢癌早期诊断中的应用价值[J].实用妇产科杂志,2018,34(4):314-316. [18] MONTAGNANA M,BENATI M,DANESE E.Circulating biomarkers in epithelial ovarian cancer diagnosis:from present to future perspective[J].Ann Transl Med,2017,5(13):276. |